10.46
price down icon3.37%   -0.3649
after-market Handel nachbörslich: 10.60 0.14 +1.34%
loading

Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
5.66%
3.9432
4.1796 4.2484 3.4953 4.4552
Operating Income/Loss
5.66%
-3.9432
-4.1796 -4.2484 -3.4953 -4.4552
Nonoperating Income/Loss
22.78%
0.1366
0.1769 0.326 0.2502 0.2019
Income/Loss From Continuing Operations Before Tax
4.84%
-3.8067
-4.0003 -3.9224 -3.2451 -4.2532
Income/Loss From Continuing Operations After Tax
4.90%
-3.8067
-4.0028 -3.9224 -3.2451 -4.2532
Net Income/Loss
4.90%
-3.8067
-4.0028 -3.9224 -3.2451 -4.2532
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
8.4424
- 8.401 8.401 8.401
Diluted Average Shares
8.4424
- 8.401 8.401 -
Basic Earnings Per Share
4.26%
-0.45
-0.47 -0.47 -0.39 -0.51
Diluted Earnings Per Share
4.26%
-0.45
-0.47 -0.47 -0.39 -0.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Kapitalisierung:     |  Volumen (24h):